Business Description
Instil Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US45783C1018
Description
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FR?, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.41 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.48 | |||||
| Debt-to-EBITDA | -1.34 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -60.9 | |||||
| 3-Year EPS without NRI Growth Rate | -28.4 | |||||
| 3-Year FCF Growth Rate | -6.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 57.67 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.38 | |||||
| 9-Day RSI | 46.27 | |||||
| 14-Day RSI | 44.47 | |||||
| 6-1 Month Momentum % | 224.62 | |||||
| 12-1 Month Momentum % | 399.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.9 | |||||
| Quick Ratio | 12.9 | |||||
| Cash Ratio | 11.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.7 | |||||
| Shareholder Yield % | -0.88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -36.24 | |||||
| ROA % | -24.42 | |||||
| ROIC % | -37.98 | |||||
| ROC (Joel Greenblatt) % | -49.02 | |||||
| ROCE % | -22.74 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | -2.08 | |||||
| EV-to-Forward-EBIT | -0.82 | |||||
| EV-to-EBITDA | -2.21 | |||||
| EV-to-FCF | -2.4 | |||||
| Price-to-Net-Current-Asset-Value | 4.83 | |||||
| Price-to-Net-Cash | 7.27 | |||||
| Earnings Yield (Greenblatt) % | -48.08 | |||||
| FCF Yield % | -33.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TIL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Instil Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -11.56 | ||
| Beta | 1.76 | ||
| Volatility % | 390.48 | ||
| 14-Day RSI | 44.47 | ||
| 14-Day ATR ($) | 3.807637 | ||
| 20-Day SMA ($) | 27.7495 | ||
| 12-1 Month Momentum % | 399.42 | ||
| 52-Week Range ($) | 6.07 - 92 | ||
| Shares Outstanding (Mil) | 6.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Instil Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Instil Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Instil Bio Inc Frequently Asked Questions
What is Instil Bio Inc(TIL)'s stock price today?
The current price of TIL is $26.91. The 52 week high of TIL is $92.00 and 52 week low is $6.07.
When is next earnings date of Instil Bio Inc(TIL)?
The next earnings date of Instil Bio Inc(TIL) is 2025-03-21 Est..
Does Instil Bio Inc(TIL) pay dividends? If so, how much?
Instil Bio Inc(TIL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers